Mumbai: Several Type 1 diabetes patients in India are upset with discontinuation of a continuous glucose monitoring (CGM) sensor that has been the "most affordable" option in the country.

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.

Diabetes is a chronic condition that happens when your blood sugar levels are too high. It develops when your pancreas either does not make any insulin or is not able to use it properly.

Highland High School senior Ira Sittner has a firm handshake coupled with a nice to meet you, sir or ma’am, as he looks you directly in the eyes before letting your hand go. His name is known ...

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its revolutionary Omnipod 5 Automated Insulin ...

Objectives To assess the feasibility and change in clinical outcomes associated with continuous glucose monitoring (CGM) use among a rural population in Malawi living with type 1 diabetes. Design A ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation ...

Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U ...

The following is a summary of “Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in ...

Medical Sensors Market Size & Growth Insights: According to the SNS Insider Report, “The Medical Sensors Market Size was valued at USD 43.21 billion in 2023 and is expected to reach USD 209.70 billion ...